Ann: BTM delivers positive First in Man results in Cell Therapies, page-39

So this is a huge announcement, way bigger than some might realise

It is essentially a definitive achievement in validating Polynovos products for Cell Therapies across the board. While Beta Cell isnt a giant company, there are plenty of other companies out their facing the same issue, how to successfully transport cells in vivo while maintaining efficacy. These companies specialise in the treatment, but will need vehicles like BTM to transport these therapies and greatly improve results. This should see future collaborations with other Cell therapy and drug therapy companies, who desire to increase efficacy of their delivery system. This isn't something that is easily produced in house, and so outsourcing this to companies like PNV seem to be the only realistic option. By publicising this achievement, it opens the door for other companies to initiate deals and negotiations for collaboration

This study validates BTMs ability to be that vehicle, and I'm sure other similar companies to Beta Cell, or even bio giants like J&J would have a keen interest in leveraging PNVs technology.

The company has completely shed its initial identity known for external applications like burns, at this point its use case is expanding to a brilliant multipurpose application for not only healing wounds and supporting bodily structures, but now delivering cells or even drugs to the body

I've been extremely critical of Polynovos front office management under SR, but ill now concede with his removal from the company things seem to have turned a corner. We have active promotion of the company for once, public collaborations delivered to market, the return of record announcements. All these things are essential in the modern investing world that is fueled by hype and promotion. I'm at my largest holding to date after trading out at this stock on its recent downturn.

Chart wise we are primed for a rapid rise. Short squeeze is potentially on, Golden cross on the cards, Webinar up soon and hopefully another record month or future collaboration in the following month. Of PNVs 8 recent record monthly announcements, 5 of which have occurred in May or later in the calendar year. Its well overdue and this stock has woefully underperformed expectations on the chart, but im hoping that regression to the mean brings about a powerful 2H of the year. Its all about maintaining that momentum, which SR crushed with things like removing record announcements.

I can easily see a pathway, reliant on the overall market not declining and the continuation of momentum, with a touch of short squeeze, where Polynovo goes beyond $3 this year to even $4. We will need to see some things fall our way but the cards are on the table for it